Bank of New York Mellon’s Accretive Health AH Stock Holding History

Bank of New York Mellon’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-308,152	Closed	-$2.82M	–	4275
2013 Q4	$2.82M	Buy	308,152 +19,512	+7%	+$168K	﹤0.01%	2660
2013 Q3	$2.63M	Buy	288,640 +801	+0.3%	+$7.96K	﹤0.01%	2665
2013 Q2	$3.11M	Buy	+287,839	New	+$3.03M	﹤0.01%	2493

Other funds holding AH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JRP

Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Bank of New York Mellon's AH Position: Q1 2014 in Review

Bank of New York Mellon sold out of Accretive Health (AH) in Q1 2014, closing a stake of 308,152 shares — an estimated $2.82M sold.

Bank of New York Mellon first reported a position in AH in Q2 2013 and held it in 3 quarters. The position peaked at $3.11M in Q2 2013. 66 funds tracked by Wall St. Rank hold AH as of Q1 2014.

Bank of New York Mellon reported no remaining Accretive Health position as of Q1 2014 after selling out during the quarter.
Bank of New York Mellon sold 308,152 Accretive Health shares in Q1 2014, an estimated $2.82M.
Bank of New York Mellon first reported a position in Accretive Health in Q2 2013 and held it in 3 quarters.
Bank of New York Mellon's Accretive Health position peaked at $3.11M in Q2 2013.
66 funds tracked by Wall St. Rank held Accretive Health as of Q1 2014.

Based on Bank of New York Mellon's 13F filing for Q1 2014, filed 14 May 2014.